Dexmedetomidine for treating agitation associated with schizophrenia [TSID10726]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Severe and enduring mental illness guidance reviewStatus:In developmentProgramme:NICE guidelineExpected publication date: TBC